Hazha Abdullah Mohammed Ameen a

a Department of Medicine, College of Medicine, University of Sulaimani. 

Submitted: 2/3/2018; Accepted: 12/8/2018; Published 15/10/2018

DOI Link: https://doi.org/10.17656/jsmc.10167 



Obesity has been documented as an important prognostic factor and increased mortality with each successive increase in body mass index (BMI). It is unclear whether these associations differ among breast cancer subtypes.


To know the association of the Allred score which has both predictive and prognostic value, with the body mass index in Kurdish Premenopausal women with breast cancer.

Patients and Methods

This study carried out at Hiwa hematology/oncology hospital of Sulaimani between June 2007 to December of 2015. Age, menopausal status, hormone receptor, Her-2 neu status height, weight, and body mass index were studied. Allred score by immunohistochemistry of all breast cancer patients was retrospectively analyzed.


We conducted a population-based case-case study consisting of 519 women diagnosed with invasive breast cancer. Mean age of the studied group was 47.3±9.2 years. Mean menopausal age was 51±3 years; almost two-thirds of whom were premenopausal. Mean BMI of breast cancer patients was 30.1±5.6 kg/m2; 47% were obese. There was a strong association between high BMI and breast cancer in the age period of 40 to 49 years (p=0.03). The obese patient had a high tumor grade, ki67 and stage III disease. Strong expression of both Estrogen and progesterone receptors were observed in obese premenopausal patients.


Obese women usually presented with an increased risk of breast cancer in premenopausal women, advanced stage, and the majority of them had positive hormonal receptor status (ER/PR) Estrogen Receptor /Progesterone Receptor. Fortunately, obese linked to high Allred score with good response to hormonal therapy and better survival.


Breast Cancer, Body Mass Index, Obesity, Estrogen Receptor, Allred Score.


1. Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 19(3): 421-30.

2. World Cancer Research Fund International. Food, Nutrition, Physical Activity, and the Prevention of Cancer:a global perspective. Washington, USA. American Institute for Cancer Research; 2007. www.aicr.org, (Accessed may 2015).

3. Ligibel J. . Obesity and breast cancer. Oncology 2011; 25(11): 994-1000.

4. Niraula S1, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat 2012; 134(2): 769-81. 

5. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis.Breast Cancer Res Treat 2010; 123(3):627-35.  6. Alyssa J. Cozzo1, Ashley M. Contribution of Adipose Tissue to Development of Cancer .Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North CarolinaCompr Physiol . ; 8(1): 237–282

7. Harvey JM, Clark GM, Osborne CK : Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474-1481, 1999.

8. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006; 13(2): 279–92.

9. Jensen EV., Mechanism of estrogen action in relation to carcinogenesis. Proc Can Cancer Conf 1966; 6:143-165.

10. AL- Safi AMH, Yassin BAG, AL- Tameemi EA. body mass index among women with proved or suspected breast cancer attending national center for early detection. Medical City Campus. IOSR Journal of Dental and Medical Sciences 2015; 14(5): 53-59.

11. Calle EE, Kaaks R ,Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004(4):579–591

12. Karim SAM, Ghalib HHA, Fattah FHR, Gubari MIM, Majeed AB. Height, weight, and body mass index association with breast cancer risk in Iraqi Kurdish women. Case Studies in Surgery 2015; 1(1):1-7.

13. Cleary MP, Grossmann ME. Obesity and Breast cancer: the estrogen connection. Endocrinology 2009; 150: 2537-42.

14. Ruunak A Majid, Hazha A Mohammed, Heshu M Saeed, et al. Breast cancer in kurdish women of northern Iraq: incidence, clinical stage, and case control analysis of parity and family risk. BMC women's health 2009; 9(33):12-16.

15. Elkum N, Al-Tweigeri T, Ajarim D, Al-Zahrani A, Amer SMB, Aboussekhra A. Obesity is a significant risk factor for breast cancer in Arab women. BMC Cancer 2014; 14:788. 

16.Gershuni VM, Ahima RS, Tchou J Obesity and breast cancer: a complex relationship. Curr Surg Rep 2016: 4:1–9

17. Saibara T, Ogawa Y, Onishi S. Early breast cancer trialists’ collaborative group. tamoxifen for early breast cancer: an overview of randomized trials. Lancet 1998; 351(9114): 1451–1467.

18. Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogenprogestin use and hormone receptor status. Epidemiol Rev. 2014;36:114–36.

19. Lesley A Stead, Timothy L Lash, Jerome E Sobieraj, Dorcas D Chi.: Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Research 2009; 11((2):18

20. Dignam JJ, Wieand K, Johnson KA. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 2003; 95:1467-1476.

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.